Skip to main content

Table 1 Presence of BPV-1 and immunohistochemical expression of BAG3 in equine sarcoids

From: BAG3 protects Bovine Papillomavirus type 1-transformed equine fibroblasts against pro-death signals

Samples* Clinical type BPV-1 DNA BAG3 immunohistochemical staining**
T1 Nodular + +++
T2 Mixed + +/−
T3 Verrucous + ++
T4 Fibroblastic + ++
T5 Flat + +++
T6 Verrucous + ++
T7 Mixed + ++
T8 Flat + +/−
T9 Fibroblastic + n.a.
T10 Verrucous + +++
T11 Verrucous + +++
T12 Nodular + ++
T13 Verrucous + n.a.
T14 Nodular + +
T15 Mixed + +
N1 Normal skin + +
N2 Normal skin n.a. +/−
N3 Normal skin n.a. +/−
N4 Normal skin n.a. +/−
N5 Normal skin n.a. +/−
  1. *T: tumour sample; N: normal skin sample.
  2. **Immunoreactivity scoring was determined by two observers. The intensity of immune labelling for each specimen was scored on a four-tiered scale: +/−, very weak signal; +, weak signal; ++, moderate signal; +++, strong signal; n.a., not assessable.